On an article published by the National Institute of Health, trial results has proved that prolonged reduction of relapsing MS (multiple Sclerosis) can be induced by a high-dosage immunosuppressive therapy together with a transplant of stem cells which have been formed from a patient’s own blood. Multiple Sclerosis can be described as an autoimmune disorder in which the central nervous system is attacked by the immune system. The new trial results have provided a new and effective treatment of multiple sclerosis. According to National Institute of Health, 69% of all trial participants managed to survive without relapse of the MS symptoms, new brain lesions or even progression of disability after getting the treatment of HDIT/HCT for five years.
It was also noted that none of the participants took any medications for Multiple Sclerosis after getting the HDIT/HCT. Research also suggests that MS medications that are currently available have reduced rates of success. The study was known as HALT-MS and the National Institute of Allergy and Infectious Diseases acted as the sponsors. The trial was conducted by Immune Tolerance Network. The published results took 3 years and new results are set to be published on the American Academy of Neurology’s medical journal known as Neurology. Multiple Sclerosis may manifest itself with different symptoms such as fatigue, chronic pain, weakness and difficulties in speech.
Dr. Shiva Vasishta serves as a neurologist and is based in Voorhees, New Jersey. Dr. Shiva is an affiliate of the Kennedy University Hospital. He has acquired a reputation as a neurologist who is efficient, hard working and reliable. He attended the Government Medical College Nagpur where he managed to get his Medical Degree. Dr. Shiva Vasishta has 20 years worth of experience and has accumulated a lot of skills in his field of work. He is one of the 34 doctors working at the Kenney University Hospital whose specialty is in Neurology.